Articles

Ponatinib as targeted therapy for FGFR1 fusions associated with the 8p11 myeloproliferative syndrome

Wessex Regional Genetics Laboratory, Salisbury, UK and Faculty of Medicine, University of Southampton, UK
Wessex Regional Genetics Laboratory, Salisbury, UK and Faculty of Medicine, University of Southampton, UK
Wessex Regional Genetics Laboratory, Salisbury, UK and Faculty of Medicine, University of Southampton, UK
Wessex Regional Genetics Laboratory, Salisbury, UK and Faculty of Medicine, University of Southampton, UK
Vol. 98 No. 1 (2013): January, 2013 https://doi.org/10.3324/haematol.2012.066407